A Study of Mood Symptoms in Epilepsy Patients


About this study

The purpose of this study is to track neuropsychiatric symptoms in patients with epilepsy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients admitted to Saint Mary’s Hospital for EEG monitoring or inpatient psychiatric treatment;
  • Patients aged 18 or above;
  • Patients possessing written and spoken English language proficiency; and
  • Patients able to provide consent will be invited to participate. Patients that are anticipated to be implanted with intracranial EEG electrodes may be prioritized for this study, including patients implanted with depth electrodes and/or subdural neocortical strips or grids.

Exclusion Criteria:

  • Patients with an inability to provide informed consent;
  • Patients with an inability to complete study materials secondary to cognitive, psychiatric, or other medical impairment; and/or
  • Patients with secondary-to-limited English language fluency as determined by EMU or Generose staff and Dr. Greg Worrell.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Gregory Worrell, M.D., Ph.D.

Open for enrollment

Contact information:

Karla Crockett

(507) 538-4880


More information


Publications are currently not available

Mayo Clinic Footer